LABEX Projects

The CEISAM Laboratory is involved in 3 NEXT-funded LABEX projects.
The NEXT Labexes are interdisciplinary research projects that will provide a structure for the Nantes region, and which aim to strengthen the excellence and influence of research in the two areas covered by the NEXT I-site: health and the industry of the future.
These Labexes will contribute to meeting major societal challenges by drawing on the dynamism and high-level expertise of Nantes' laboratories and research teams.
Led by Stéphane CARO (LS2N - Laboratoire des Sciences du Numérique de Nantes - Nantes Université / Centrale Nantes / IMT Atlantique / CNRS / Inria)
Year of certification : 2025
Financials: 1 780 000 €
IMAF aims to put people at the heart of the manufacturing production process, by focusing on human-machine collaboration and autonomous decision-making systems for tasks requiring creativity and complex, rapid decision-making.
The Labex will focus on five challenges: manufacturing as a service; agile robotics; digital twins; human factors; and metal, composite and chemical processes.
Led by Françoise KRAEBER-BODERE (CRCI²NA - Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers Inserm UMR 1307 CNRS UMR 6075/ Service de Médecine Nucléaire CHU de Nantes)
Year of certification : 2024
Project years : 04/01/2025 to 12/31/2029
Financials: 1 776 000 €
DHOLMEN aims to structure a program of fundamental, translational and clinical research to advance precision medicine in hematology and nuclear oncology.
DHOLMEN will address interdisciplinary scientific issues around 3 major themes: 1- Artificial intelligence: prognostic biomarkers and risk assessment, 2- Theranostics: combined diagnosis and therapy in nuclear medicine, 3- Targeted Alpha-Therapy; and organizational and medico-economic issues, ensuring a holistic approach to healthcare innovation.
These issues will be developed in 6 scientific Work Packages, complemented by 3 structuring Work Packages (Education/Training, Technology Transfer, Site Structuring).
Led by :